Drug intelligence / Profile preview

AAV-leptin

Development stage
Preclinical
Lead developer
Massachusetts Institute of Technology
Modality
Gene Addition/Replacement → Gene Therapies, Gene Editing → Gene Therapies, Gene Silencing → Gene Therapies
Administration
Intramuscular, Intraperitoneal
01

Overview

AAV-leptin is an experimental gene therapy construct designed to deliver a functional leptin (LEP) gene using a recombinant adeno-associated virus (AAV) vector. It is primarily used in preclinical research to restore circulating leptin levels in models of congenital leptin deficiency, such as ob/ob mice. By providing a sustained source of leptin, the therapy aims to normalize metabolic abnormalities, including obesity, hyperglycemia, and insulin resistance. Research has also explored its role in intercepting obesity-mediated cancer progression, particularly in pancreatic cancer models. Various serotypes and targeting variants, such as adipose-targeting Rec2-leptin, have been investigated across multiple academic institutions.

Other names
recombinant adeno-associated virus-leptinAAV-LEP
02

Targets

LEPR (Leptin receptor)

Beyond the preview

Go deeper on AAV-leptin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AAV-leptin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call